Biotech

Microbix Reports Fiscal 2015 Results Continued Profitability and Revenue Growth

TORONTO, ONTARIO: Updates on LumiSort(TM) and Kinlytic(R) Partnering Discussions Provided ...

Hemostemix Joins the OTCQX Marketplace in the United States

TORONTO, ONTARIO: ...

Lifeline Biotechnologies Summarizes 2015, Looks Forward to 2016

RENO, NV: Lifeline Biotechnologies Recaps 2015 Activity and Forecasts 2016 Expectations ...

Flamel Technologies Announces Positive Interim Results of a First-in-Man Clinical Trial With Medusa(TM) Exenatide

LYON, FRANCE: ...

Prima BioMed Initiates Phase IIb Study in Metastatic Breast Cancer

SYDNEY, AUSTRALIA: ...

Change of Leadership at Novimmune S.A.

GENEVA, SWITZERLAND: ...

Sernova Awarded Europe''s Prestigious Horizon 2020 Grant to Fund Development of Cell-Based Hemophilia Therapeutic Product Into the Clinic

LONDON, ONTARIO: Distinguished European Consortium Awarded Approximately $8.5 Million CAD by the European Commission via Its Horizon 2020 Program to Partner Advanced Cell Based Factor VIII Therapy in Collaboration Wit ...

Threshold Pharmaceuticals Announces Workforce Reduction

SOUTH SAN FRANCISCO, CA: Threshold to Focus on Clinical Trials of Tarloxotinib While Evaluating Potential Further Development of Evofosfamide and Other Strategic Options for the Company ...

Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00

SAN FRANCISCO, CA: ...

Atossa Genetics Completes Sale of Its Wholly-Owned Subsidiary The National Reference Laboratory for Breast Health, Inc.

SEATTLE, WA: Atossa Retains 19% Ownership Through Preferred Stock ...